Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Agilent Technologies Receives FDA Approval For MAGE-A4 IHC 1F9 pharmDx As Diagnostic Tool To Identify Synovial Sarcoma Patients Eligible For TECELRA TCR T-Cell Therapy

Author: Benzinga Newsdesk | August 02, 2024 08:03am

Posted In: A

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist